Background The incidence of papillary thyroid cancer (PTC) continues to rise all over the
world, 10–15% of the patients have a poor prognosis. Although immunotherapy has been …

Papillary thyroid cancer (PTC) is the most common thyroid malignancy. Although PTC
usually has a favorable prognosis, some aggressive PTC subtypes and lymph node (LN) …

Background The tumor microenvironment (TME) plays a pivotal role in cancer progression in
papillary thyroid carcinoma (PTC), yet the composition and the phenotype of cells within the …

The prevalence of thyroid carcinoma is increasing and represents the most common
endocrine malignancy, with papillary thyroid carcinoma (PTC) being the most frequent …

Background Papillary thyroid carcinoma (PTC) is globally prevalent and associated with an
increased risk of lymph node metastasis (LNM). The role of cancer-associated fibroblasts …

Background Papillary thyroid carcinoma (PTC) is the main pathological type of thyroid
carcinoma (TC). Gender is a prominent background parameter for patients with PTC. Here …

Background Papillary thyroid cancer has been associated with chronic inflammation. A
systematic understanding of immune cell infiltration in PTC is essential for subsequent …

Background Lymphocytic thyroiditis (LT) is frequently seen in the tumor microenvironment
(TME) of papillary thyroid carcinomas (PTCs). However, the characteristic of these tumor …

Regional lymph node metastasis (LNM) increases the risk of distant metastasis in papillary
thyroid cancer (PTC) patients. However, it remains unclear how tumor cells in PTC patients …

Background Thyroid tissue has a special immune microenvironment that is not well
characterized. Whether immune cells have a prognostic value in the recurrence of papillary …